EU Policies
-
News
NEW FACTSHEET | The Advanced Therapy Medicinal Products (ATMPs) Labyrinth
Featuring comprehensive information on: The Regulation of ATMPs in the EU List of gene-based products approved by the EMA/FDA Challenges in Patient Access to ATMPs Key Recommendations for Improving Patient…
Read More » -
News
TIF’s EXECUTIVE DIRECTOR | Patient Blood Management Should Not Be Overlooked In EU’s Blood Revision
**Reposting from Euractiv’s website. How important are blood transfusions for thalassemia patients? Blood transfusion therapy constitutes the cornerstone of managing these patients, who, in the absence of management, develop…
Read More »